Ocular Therapeutix(OCUL)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

OCUL Ocular Therapeutix

未开盘 12-17 16:00:00 EST

13.72

-0.67

-4.66%

盘后13.82

+0.10+0.73%

19:25 EST

最高14.64	最低13.59	成交量322.46万
今开14.35	昨收14.39	日振幅7.30%
总市值29.23亿	流通市值25.11亿	总股本2.13亿
成交额4,445万	换手率1.76%	流通股本1.83亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"OCUL","market":"US","secType":"STK","nameCN":"Ocular Therapeutix","latestPrice":13.72,"timestamp":1766005200000,"preClose":14.39,"halted":0,"volume":3224616,"hourTrading":{"tag":"盘后","latestPrice":13.82,"preClose":13.72,"latestTime":"19:25 EST","volume":123173,"amount":1690693.74,"timestamp":1766017549762},"delay":0,"floatShares":183000000,"shares":213047472,"eps":-1.438704,"marketStatus":"未开盘","change":-0.67,"latestTime":"12-17 16:00:00 EST","open":14.35,"high":14.64,"low":13.59,"amount":44446665.540648,"amplitude":0.072967,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.438704,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1766048400000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1406260800000,"exchange":"NASDAQ","adjPreClose":14.39,"preHourTrading":{"tag":"盘前","latestPrice":14.49,"preClose":14.39,"latestTime":"09:25 EST","volume":2617,"amount":38192.647168999996,"timestamp":1765981501168},"postHourTrading":{"tag":"盘后","latestPrice":13.82,"preClose":13.72,"latestTime":"19:25 EST","volume":123173,"amount":1690693.74,"timestamp":1766017549762},"volumeRatio":0.963445,"optionData":{"bulkOrders":[{"symbol":"OCUL","call":false,"expireDate":1773979200000,"strike":"5.0","timestamp":1766003743963,"price":0.2,"volume":2000,"amount":40000,"type":"-"}]},"impliedVol":0.9269,"impliedVolPercentile":0.792},"requestUrl":"/m/hq/s/OCUL/wiki","defaultTab":"wiki","newsList":[{"id":"1152036895","title":"Ocular Therapeutix™计划加速Axpaxli™在湿性年龄相关性黄斑变性治疗中的NDA提交时间表","url":"https://stock-news.laohu8.com/highlight/detail?id=1152036895","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1152036895?lang=zh_cn&edition=full","pubTime":"2025-12-08 20:02","pubTimestamp":1765195350,"startTime":"0","endTime":"0","summary":"Ocular Therapeutix™计划加速Axpaxli™在湿性年龄相关性黄斑变性（Wet AMD）治疗中的NDA提交时间表。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","OCUL"],"gpt_icon":0},{"id":"1150807524","title":"Ocular Therapeutix 根据纳斯达克上市规则5635(C)(4)报告激励授予","url":"https://stock-news.laohu8.com/highlight/detail?id=1150807524","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1150807524?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:10","pubTimestamp":1763572231,"startTime":"0","endTime":"0","summary":"11月7日 - Ocular Therapeutix Inc ::*Ocular Therapeutix™ 根据纳斯达克上市规则5635(C)(4)报告激励授予","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","OCUL"],"gpt_icon":0},{"id":"2584220153","title":"Ocular Therapeutix, Inc.盘中异动 大幅拉升5.02%报12.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584220153","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584220153?lang=zh_cn&edition=full","pubTime":"2025-11-20 00:10","pubTimestamp":1763568608,"startTime":"0","endTime":"0","summary":"北京时间2025年11月20日00时10分，Ocular Therapeutix, Inc.股票出现异动，股价急速拉升5.02%。Ocular Therapeutix, Inc.股票所在的生物技术行业中，整体跌幅为0.90%。其相关个股中，Nuvation Bio Inc.、Kazia Therapeutics Limited、Klotho Neurosciences Inc C/Wts 21/06/2029 涨幅较大，Kazia Therapeutics Limited、Clearmind Medicine Inc.、Can Fite Biopharma Ltd较为活跃，换手率分别为1337.49%、133.36%、52.08%，振幅较大的相关个股有Tempest Therapeutics, Inc.、Nuvation Bio Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 ，振幅分别为47.58%、40.21%、32.83%。Ocular Therapeutix, Inc.公司简介：Oural Therapeutix Inc 是一家生物技术公司，专门从事眼部疾病和病症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251120001008a704c140&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251120001008a704c140&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","OCUL"],"gpt_icon":0},{"id":"2572552335","title":"Ocular Therapeutix, Inc.盘中异动 股价大涨5.39%报12.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2572552335","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2572552335?lang=zh_cn&edition=full","pubTime":"2025-10-01 21:32","pubTimestamp":1759325538,"startTime":"0","endTime":"0","summary":"北京时间2025年10月01日21时32分，Ocular Therapeutix, Inc.股票出现异动，股价大幅上涨5.39%。截至发稿，该股报12.32美元/股，成交量15.3595万股，换手率0.07%，振幅1.92%。Ocular Therapeutix, Inc.股票所在的生物技术行业中，整体涨幅为1.15%。Ocular Therapeutix, Inc.公司简介：Oural Therapeutix Inc 是一家生物技术公司，专门从事眼部疾病和病症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251001213219a4502d90&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251001213219a4502d90&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","OCUL"],"gpt_icon":0},{"id":"2565256296","title":"Ocular Therapeutix, Inc.盘中异动 股价大涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2565256296","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565256296?lang=zh_cn&edition=full","pubTime":"2025-09-05 23:36","pubTimestamp":1757086584,"startTime":"0","endTime":"0","summary":"北京时间2025年09月05日23时36分，Ocular Therapeutix, Inc.股票出现波动，股价急速拉升5.12%。Ocular Therapeutix, Inc.股票所在的生物技术行业中，整体涨幅为1.04%。其相关个股中，Protagenic Therapeutics Inc C/Wts 26/04/2026 、Cingulate Inc C/Wts 10/12/2026 、Olema Pharmaceuticals, Inc.涨幅较大，Cero Therapeutics Holdings, Inc.、Novabay Pharmaceuticals, Inc.、Purple Biotech Ltd较为活跃，换手率分别为358.89%、110.72%、55.36%，振幅较大的相关个股有Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Psyence Biomedical Ltd C/Wts 25/01/2029、Apollomics Inc C/Wts 01/04/2028 ，振幅分别为37.30%、32.78%、31.75%。Ocular Therapeutix, Inc.公司简介：Oural Therapeutix Inc 是一家生物技术公司，专门从事眼部疾病和病症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250905233624977a985c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250905233624977a985c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUL","BK4007"],"gpt_icon":0},{"id":"2557010328","title":"美股财报 | Ocular Therapeutix发布Q2财报 前半年累计净亏损同比扩大21.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557010328","media":"同花顺iNews","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557010328?lang=zh_cn&edition=full","pubTime":"2025-08-06 14:00","pubTimestamp":1754460013,"startTime":"0","endTime":"0","summary":"ocular therapeutix发布Q2财报，2025财年前六月累计收入2415.60万美元，去年同期累计收入为3121.50万美元，同比减少22.61%。ocular therapeutix, Inc.于2006年9月12号在特拉华州成立。该公司基于水凝胶的生物可吸收候选产品的设计是给眼睛提供持续的治疗药物缓释。公司的泪小管栓候选产品结合了公司的水凝胶技术同美国食品和药物管理局，或FDA批准的治疗药物对眼睛提供持续给药目的。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806140531a4780613&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806140531a4780613&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUL"],"gpt_icon":0},{"id":"1128882040","title":"异动解读 | Ocular Therapeutix股价盘中暴跌近14%，季度业绩不及预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1128882040","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1128882040?lang=zh_cn&edition=full","pubTime":"2025-08-05 22:23","pubTimestamp":1754403827,"startTime":"0","endTime":"0","summary":"眼科医疗公司Ocular Therapeutix今日盘中股价大跌，截至发稿时跌幅高达13.93%。这一显著跌幅主要源于公司最新发布的季度财报未能达到市场预期。根据Ocular Therapeutix公布的财报显示，截至6月30日的季度中，公司调整后每股亏损39美分，低于分析师平均预期的35美分亏损。尽管Ocular Therapeutix今年以来的股价表现较好，年初至今上涨44.6%，但这份不及预期的财报似乎打击了投资者信心。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["OCUL"],"gpt_icon":0},{"id":"2557602392","title":"Ocular Therapeutix, Inc.盘中异动 早盘快速跳水7.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557602392","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557602392?lang=zh_cn&edition=full","pubTime":"2025-08-05 21:31","pubTimestamp":1754400719,"startTime":"0","endTime":"0","summary":"北京时间2025年08月05日21时31分，Ocular Therapeutix, Inc.股票出现波动，股价大幅下跌7.13%。Ocular Therapeutix, Inc.股票所在的生物技术行业中，整体跌幅为2.54%。其相关个股中，Y-Mabs Therapeutics, Inc.、Shattuck Labs, Inc.、Adaptimmune Therapeutics Plc涨幅较大，Shattuck Labs, Inc.、Adaptimmune Therapeutics Plc、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为100.99%、74.86%、61.84%，振幅较大的相关个股有Plus Therapeutics, Inc.、Cellectis Ads Each Repr 1 Ord Spon、Shattuck Labs, Inc.，振幅分别为12.18%、10.60%、10.37%。Ocular Therapeutix, Inc.公司简介：Oural Therapeutix Inc 是一家生物技术公司，专门从事眼部疾病和病症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805213159a6d49da1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805213159a6d49da1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","OCUL"],"gpt_icon":0},{"id":"2550659244","title":"Ocular Therapeutix, Inc.盘中异动 快速拉升5.03%报10.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550659244","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550659244?lang=zh_cn&edition=full","pubTime":"2025-07-09 22:39","pubTimestamp":1752071999,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日22时39分，Ocular Therapeutix, Inc.股票出现波动，股价快速上涨5.03%。Ocular Therapeutix, Inc.股票所在的生物技术行业中，整体涨幅为1.27%。其相关个股中，Calidi Biotherapeutics, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 涨幅较大，Calidi Biotherapeutics, Inc.、Kazia Therapeutics Limited、Mustang Bio, Inc.较为活跃，换手率分别为1059.74%、704.96%、521.27%，振幅较大的相关个股有Calidi Biotherapeutics, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Prokidney Corp.，振幅分别为173.13%、112.02%、48.79%。Ocular Therapeutix, Inc.公司简介：Oural Therapeutix Inc 是一家生物技术公司，专门从事眼部疾病和病症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709224000979fc586&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709224000979fc586&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUL","BK4007"],"gpt_icon":0},{"id":"2549743523","title":"Ocular Therapeutix, Inc.盘中异动 股价大涨5.10%报10.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549743523","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549743523?lang=zh_cn&edition=full","pubTime":"2025-07-08 22:06","pubTimestamp":1751983582,"startTime":"0","endTime":"0","summary":"北京时间2025年07月08日22时06分，Ocular Therapeutix, Inc.股票出现异动，股价快速拉升5.10%。Ocular Therapeutix, Inc.股票所在的生物技术行业中，整体涨幅为0.60%。其相关个股中，Prokidney Corp.、Moleculin Biotech, Inc.、Rallybio Corporation涨幅较大，Zyversa Therapeutics, Inc.、Rallybio Corporation、Moleculin Biotech, Inc.较为活跃，换手率分别为854.34%、240.92%、166.61%，振幅较大的相关个股有Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Moleculin Biotech, Inc.、Prokidney Corp.，振幅分别为70.97%、69.44%、62.64%。Ocular Therapeutix, Inc.公司简介：Oural Therapeutix Inc 是一家生物技术公司，专门从事眼部疾病和病症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708220622a43e3f9a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708220622a43e3f9a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUL","BK4007"],"gpt_icon":0},{"id":"2548814745","title":"Ocular Therapeutix, Inc.盘中异动 股价大涨5.16%报9.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548814745","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548814745?lang=zh_cn&edition=full","pubTime":"2025-07-03 02:13","pubTimestamp":1751479982,"startTime":"0","endTime":"0","summary":"北京时间2025年07月03日02时13分，Ocular Therapeutix, Inc.股票出现波动，股价急速上涨5.16%。Ocular Therapeutix, Inc.股票所在的生物技术行业中，整体涨幅为0.99%。其相关个股中，Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Nutriband Inc C/Wts 、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025涨幅较大，Sonnet Biotherapeutics Holdings, Inc.、Windtree Therapeutics, Inc.、Lixte Biotechnology Holdings, Inc.较为活跃，换手率分别为2582.16%、2044.96%、1269.11%，振幅较大的相关个股有Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Sonnet Biotherapeutics Holdings, Inc.，振幅分别为1145.92%、393.59%、152.07%。Ocular Therapeutix, Inc.公司简介：Oural Therapeutix Inc 是一家生物技术公司，专门从事眼部疾病和病症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070302130295343886&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070302130295343886&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","OCUL"],"gpt_icon":0},{"id":"2547973340","title":"Ocular Therapeutix, Inc.盘中异动 急速拉升5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2547973340","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547973340?lang=zh_cn&edition=full","pubTime":"2025-06-30 21:35","pubTimestamp":1751290559,"startTime":"0","endTime":"0","summary":"北京时间2025年06月30日21时35分，Ocular Therapeutix, Inc.股票出现异动，股价急速拉升5.10%。Ocular Therapeutix, Inc.股票所在的生物技术行业中，整体涨幅为0.31%。其相关个股中，Artelo Biosciences, Inc.、Klotho Neurosciences, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 涨幅较大，Artelo Biosciences, Inc.、Klotho Neurosciences, Inc.、Inmune Bio Inc.较为活跃，换手率分别为2079.66%、119.30%、67.15%，振幅较大的相关个股有Artelo Biosciences, Inc.、Liminatus Pharma Inc C/Wts 30/04/2030 、Exicure, Inc.，振幅分别为43.74%、31.37%、16.13%。Ocular Therapeutix, Inc.公司简介：Oural Therapeutix Inc 是一家生物技术公司，专门从事眼部疾病和病症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630213600a726451d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630213600a726451d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUL","BK4007"],"gpt_icon":0},{"id":"2546249360","title":"Ocular Therapeutix, Inc.盘中异动 早盘急速跳水5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546249360","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546249360?lang=zh_cn&edition=full","pubTime":"2025-06-25 22:20","pubTimestamp":1750861248,"startTime":"0","endTime":"0","summary":"北京时间2025年06月25日22时20分，Ocular Therapeutix, Inc.股票出现波动，股价快速下挫5.01%。Ocular Therapeutix, Inc.股票所在的生物技术行业中，整体跌幅为0.83%。其相关个股中，Plus Therapeutics, Inc.、Seastar Medical Holding Corporation、内克塔治疗涨幅较大，Plus Therapeutics, Inc.、Seastar Medical Holding Corporation、Zyversa Therapeutics, Inc.较为活跃，换手率分别为950.11%、355.59%、219.24%，振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Seastar Medical Holding Corporation、Seastar Medical Holding Corp C/Wts 28/10/2027 ，振幅分别为137.04%、76.95%、53.06%。Ocular Therapeutix, Inc.公司简介：Oural Therapeutix Inc 是一家生物技术公司，专门从事眼部疾病和病症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625222049978e8e33&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625222049978e8e33&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","OCUL"],"gpt_icon":0},{"id":"2545238994","title":"Ocular Therapeutix, Inc.盘中异动 早盘大幅上涨5.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2545238994","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545238994?lang=zh_cn&edition=full","pubTime":"2025-06-24 21:31","pubTimestamp":1750771871,"startTime":"0","endTime":"0","summary":"北京时间2025年06月24日21时31分，Ocular Therapeutix, Inc.股票出现异动，股价急速上涨5.73%。Ocular Therapeutix, Inc.股票所在的生物技术行业中，整体涨幅为0.60%。其相关个股中，内克塔治疗、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Klotho Neurosciences Inc C/Wts 21/06/2029 涨幅较大，Adial Pharmaceuticals, Inc、Ibio, Inc.、Plus Therapeutics, Inc.较为活跃，换手率分别为493.39%、275.03%、213.15%，振幅较大的相关个股有内克塔治疗、Savara, Inc.、Kazia Therapeutics Limited，振幅分别为12.89%、8.79%、7.68%。Ocular Therapeutix, Inc.公司简介：Oural Therapeutix Inc 是一家生物技术公司，专门从事眼部疾病和病症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624213112a4bb9579&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624213112a4bb9579&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","OCUL"],"gpt_icon":0},{"id":"2518440695","title":"Ocular Therapeutix, Inc.2024财年实现净利润-1.94亿美元，同比减少140.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518440695","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518440695?lang=zh_cn&edition=full","pubTime":"2025-03-09 00:01","pubTimestamp":1741449669,"startTime":"0","endTime":"0","summary":"3月9日，Ocular Therapeutix, Inc.公布财报，公告显示公司2024财年净利润为-1.94亿美元，同比减少140.28%；其中营业收入为63.72百万美元，同比增加9.03%，每股基本收益为-1.22美元。从资产负债表来看，Ocular Therapeutix, Inc.总负债1.43亿美元，其中短期债务1.93百万美元，资产负债比为3.21，流动比率为0.11。机构评级：截至2025年3月9日，当前有10家机构对Ocular Therapeutix, Inc.目标价做出预测，其中目标均价为17.90美元，其中最低目标价为14.00美元，最高目标价为22.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000230abef9832&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000230abef9832&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUL"],"gpt_icon":0},{"id":"2517543948","title":"Ocular Therapeutix, Inc.盘中异动 股价大涨5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517543948","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517543948?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:43","pubTimestamp":1741185809,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时43分，Ocular Therapeutix, Inc.股票出现波动，股价大幅上涨5.23%。Ocular Therapeutix, Inc.股票所在的生物技术行业中，整体涨幅为0.75%。其相关个股中，Chimerix, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Silexion Therapeutics Corp涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为447.21%、265.62%、205.52%，振幅较大的相关个股有Silexion Therapeutics Corp、Aditxt, Inc.、Radiopharm Theranostics Limited，振幅分别为25.23%、23.90%、23.49%。Ocular Therapeutix, Inc.公司简介：Oural Therapeutix Inc 是一家生物技术公司，专门从事眼部疾病和病症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305224329abe9b4a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305224329abe9b4a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUL","BK4007"],"gpt_icon":0},{"id":"2517606781","title":"Ocular Therapeutix, Inc.盘中异动 早盘快速拉升5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517606781","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517606781?lang=zh_cn&edition=full","pubTime":"2025-03-04 23:28","pubTimestamp":1741102080,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日23时28分，Ocular Therapeutix, Inc.股票出现异动，股价急速拉升5.15%。Ocular Therapeutix, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。其相关个股中，Cyclacel Pharmaceuticals Inc 6% Cnv Pfd Usd、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Aeon Biopharma, Inc.、Windtree Therapeutics, Inc.、Protagenic Therapeutics, Inc.较为活跃，换手率分别为1175.00%、1136.55%、697.38%，振幅较大的相关个股有Nkgen Biotech Inc C/Wts 31/05/2028、Cyclacel Pharmaceuticals Inc 6% Cnv Pfd Usd、Protagenic Therapeutics Inc C/Wts 29/04/2026 ，振幅分别为100.00%、70.63%、66.67%。Ocular Therapeutix, Inc.公司简介：Oural Therapeutix Inc 是一家生物技术公司，专门从事眼部疾病和病症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304232800abe80038&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304232800abe80038&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","OCUL"],"gpt_icon":0},{"id":"2516321672","title":"Citizens Capital Markets：维持Ocular Therapeutix(OCUL.US)评级，由优于大市调整至优于大市评级, 目标价由22.00美元调整至19.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2516321672","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516321672?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:22","pubTimestamp":1741098129,"startTime":"0","endTime":"0","summary":"Citizens Capital Markets：维持Ocular Therapeutix(OCUL.US)评级，由优于大市调整至优于大市评级, 目标价由22.00美元调整至19.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/04222248521892.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["OCUL"],"gpt_icon":0},{"id":"2516796634","title":"Ocular Therapeutix, Inc.盘中异动 早盘大幅下跌5.74%报6.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516796634","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516796634?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:44","pubTimestamp":1741013071,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时44分，Ocular Therapeutix, Inc.股票出现异动，股价大幅跳水5.74%。Ocular Therapeutix, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。其相关个股中，Entero Therapeutics Inc.、Aldeyra Therapeutics, Inc.、Osr Holdings Inc C/Wts 09/02/2028 涨幅较大，Entero Therapeutics Inc.、Allarity Therapeutics, Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为99.66%、52.66%、43.38%，振幅较大的相关个股有Entero Therapeutics Inc.、Geovax Labs Inc C/Wts 29/09/2025、Tevogen Bio Holdings Inc C/Wts 14/02/2029 ，振幅分别为55.45%、24.83%、22.27%。Ocular Therapeutix, Inc.公司简介：Oural Therapeutix Inc 是一家生物技术公司，专门从事眼部疾病和病症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303224431abe6377b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303224431abe6377b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUL","BK4007"],"gpt_icon":0},{"id":"2516268034","title":"Ocular Therapeutix(OCUL.US)：2024年Q4财报实现营收1708.3万美元，前值为1480.2万美元，预期值为1689万美元；每股收益为-0.29美元，前值为-0.35美元，预期值为-0.22美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2516268034","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516268034?lang=zh_cn&edition=full","pubTime":"2025-03-03 20:13","pubTimestamp":1741003981,"startTime":"0","endTime":"0","summary":"Ocular Therapeutix(OCUL.US)：2024年Q4财报实现营收1708.3万美元，前值为1480.2万美元，预期值为1689万美元；每股收益为-0.29美元，前值为-0.35美元，预期值为-0.22美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/03201348492142.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["OCUL"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ocutx.com","stockEarnings":[{"period":"1week","weight":-0.1097},{"period":"1month","weight":0.1539},{"period":"3month","weight":0.0795},{"period":"6month","weight":0.6876},{"period":"1year","weight":0.5211},{"period":"ytd","weight":0.6066}],"compareEarnings":[{"period":"1week","weight":-0.0235},{"period":"1month","weight":0.0086},{"period":"3month","weight":0.0138},{"period":"6month","weight":0.1298},{"period":"1year","weight":0.1111},{"period":"ytd","weight":0.1456}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Ocular Therapeutix, Inc.于2006年9月12号在特拉华州成立。该公司是一家生物制药公司，致力于通过开发和商业化针对眼部疾病和状况的创新疗法来提高人们的视力和生活质量，特别关注视网膜疾病。该公司基于水凝胶的生物可吸收候选产品的设计是给眼睛提供持续的治疗药物缓释。公司的主导候选产品是药物洗脱泪点塞OTX-DP和被插入到一个自然的开口叫坐落在靠近鼻子的眼睑的内侧部分的泪点OTX-TP。公司的泪小管栓候选产品结合了公司的水凝胶技术同美国食品和药物管理局，或FDA批准的治疗药物对眼睛提供持续给药目的。","yearOnYearQuotes":[{"month":1,"riseRate":0.454545,"avgChangeRate":0.007929},{"month":2,"riseRate":0.727273,"avgChangeRate":0.225606},{"month":3,"riseRate":0.545455,"avgChangeRate":0.02622},{"month":4,"riseRate":0.545455,"avgChangeRate":-0.035211},{"month":5,"riseRate":0.545455,"avgChangeRate":0.003915},{"month":6,"riseRate":0.454545,"avgChangeRate":0.028362},{"month":7,"riseRate":0.454545,"avgChangeRate":-0.023704},{"month":8,"riseRate":0.583333,"avgChangeRate":0.063842},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.090816},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.077156},{"month":11,"riseRate":0.666667,"avgChangeRate":0.140313},{"month":12,"riseRate":0.5,"avgChangeRate":0.07385}],"exchange":"NASDAQ","name":"Ocular Therapeutix","nameEN":"Ocular Therapeutix"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Ocular Therapeutix(OCUL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Ocular Therapeutix(OCUL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Ocular Therapeutix,OCUL,Ocular Therapeutix股票,Ocular Therapeutix股票老虎,Ocular Therapeutix股票老虎国际,Ocular Therapeutix行情,Ocular Therapeutix股票行情,Ocular Therapeutix股价,Ocular Therapeutix股市,Ocular Therapeutix股票价格,Ocular Therapeutix股票交易,Ocular Therapeutix股票购买,Ocular Therapeutix股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Ocular Therapeutix(OCUL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Ocular Therapeutix(OCUL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}